Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia.

MLA

Hernández-Rojas, Myriam L., et al. “Short-Term Effects of Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Pathologic Myopia.” Retina (Philadelphia, Pa.), vol. 27, no. 6, July 2007, pp. 707–12. EBSCOhost, https://doi.org/10.1097/GIM.0b013e3180a03276.

APA

Hernández-Rojas, M. L., Quiroz-Mercado, H., Dalma-Weiszhausz, J., Fromow-Guerra, J., Amaya-Espinosa, A., Solís-Vivanco, A., Reyna-Castelán, E., Abraham-Marín, M., Martínez-Castellanos, M. A., & Aiello, L. P. (2007). Short-term effects of intravitreal bevacizumab for subfoveal choroidal neovascularization in pathologic myopia. Retina (Philadelphia, Pa.), 27(6), 707–712. https://doi.org/10.1097/GIM.0b013e3180a03276

Chicago

Hernández-Rojas, Myriam L, Hugo Quiroz-Mercado, José Dalma-Weiszhausz, Jans Fromow-Guerra, Andrés Amaya-Espinosa, Adriana Solís-Vivanco, Elizabeth Reyna-Castelán, Maura Abraham-Marín, Maria Ana Martínez-Castellanos, and Lloyd P Aiello. 2007. “Short-Term Effects of Intravitreal Bevacizumab for Subfoveal Choroidal Neovascularization in Pathologic Myopia.” Retina (Philadelphia, Pa.) 27 (6): 707–12. doi:10.1097/GIM.0b013e3180a03276.